Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

ClinicalTrials.gov ID: NCT00049517

Public ClinicalTrials.gov record NCT00049517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 10:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Trial in Adult Acute Myeloid Leukemia: Daunorubicin Dose-Intensification Prior to Risk-Allocated Autologous Stem Cell Transplantation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Giving combination chemotherapy before a stem cell transplant helps stop the growth of cancer cells. It also helps stop the patient's immune system from rejecting the transplanted stem cells. When the healthy stem cells are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. If the patient's stem cells are to be transplanted, the patient is also treated with a monoclonal antibody, such as gemtuzumab ozogamicin, to kill any remaining cancer cells or deliver cancer-killing substances to them without harming normal cells. It is not yet known whether combination chemotherapy is more effective with or without gemtuzumab ozogamicin followed by stem cell transplant in treating acute myeloid leukemia. PURPOSE: This randomized phase III trial is studying combination chemotherapy, gemtuzumab ozogamicin, and stem cell transplant to see how well they work compared to combination chemotherapy and peripheral stem cell transplant alone in treating patients with acute myeloid leukemia.

Study identification

NCT ID
NCT00049517
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
657 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug · Procedure

Eligibility (public fields only)

Age range
16 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2002
Primary completion
Feb 28, 2009
Completion
Nov 30, 2019
Last update posted
Jun 14, 2023

2002 – 2019

United States locations

U.S. sites
98
U.S. states
19
U.S. cities
72
Facility City State ZIP Site status
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham Alabama 35294
Mayo Clinic Scottsdale Scottsdale Arizona 85259-5499
Aurora Presbyterian Hospital Aurora Colorado 80012
Penrose Cancer Center at Penrose Hospital Colorado Springs Colorado 80933
St. Anthony Central Hospital Denver Colorado 80204
Porter Adventist Hospital Denver Colorado 80210
Presbyterian - St. Luke's Medical Center Denver Colorado 80218
St. Joseph Hospital Denver Colorado 80218
Rose Medical Center Denver Colorado 80220
CCOP - Colorado Cancer Research Program Denver Colorado 80224-2522
Swedish Medical Center Englewood Colorado 80110
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction Colorado 81502
North Colorado Medical Center Greeley Colorado 80631
Sky Ridge Medical Center Lone Tree Colorado 80124
Hope Cancer Care Center at Longmont United Hospital Longmont Colorado 80502
McKee Medical Center Loveland Colorado 80539
St. Mary - Corwin Regional Medical Center Pueblo Colorado 81004
North Suburban Medical Center Thornton Colorado 80229
Exempla Lutheran Medical Center Wheat Ridge Colorado 80033
Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - West Boca Raton Florida 33428
Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus Boca Raton Florida 33486
University of Florida Shands Cancer Center Gainesville Florida 32610-0232
University of Miami Sylvester Comprehensive Cancer Center - Miami Miami Florida 33136
Winship Cancer Institute of Emory University Atlanta Georgia 30322
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611-3013
Hematology and Oncology Associates Chicago Illinois 60611
Evanston Northwestern Healthcare - Evanston Hospital Evanston Illinois 60201-1781
Midwest Center for Hematology/Oncology Joliet Illinois 60432
Joliet Oncology-Hematology Associates, Limited - West Joliet Illinois 60435
North Shore Oncology and Hematology Associates, Limited - Libertyville Libertyville Illinois 60048
La Grange Oncology Associates - Geneva Naperville Illinois 60563
Cancer Care and Hematology Specialists of Chicagoland - Niles Niles Illinois 60714
Advocate Lutheran General Cancer Care Center Park Ridge Illinois 60068-1174
Hematology Oncology Associates - Skokie Skokie Illinois 60076
Carle Cancer Center at Carle Foundation Hospital Urbana Illinois 61801
CCOP - Carle Cancer Center Urbana Illinois 61801
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46815
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202-5289
Tufts-NEMC Cancer Center Boston Massachusetts 02111
Borgess Medical Center Kalamazoo Michigan 49001
West Michigan Cancer Center Kalamazoo Michigan 49007-3731
Bronson Methodist Hospital Kalamazoo Michigan 49007
MeritCare Bemidji Bemidji Minnesota 56601
Fairview Ridges Hospital Burnsville Minnesota 55337
Mercy and Unity Cancer Center at Mercy Hospital Coon Rapids Minnesota 55433
Fairview Southdale Hospital Edina Minnesota 55435
Mercy and Unity Cancer Center at Unity Hospital Fridley Minnesota 55432
Minnesota Oncology Hematology, PA - Maplewood Maplewood Minnesota 55109
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital Minneapolis Minnesota 55407
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center Robbinsdale Minnesota 55422-2900
Mayo Clinic Cancer Center Rochester Minnesota 55905
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
Park Nicollet Cancer Center Saint Louis Park Minnesota 55416
United Hospital Saint Paul Minnesota 55102
Ridgeview Medical Center Waconia Minnesota 55387
Minnesota Oncology Hematology, PA - Woodbury Woodbury Minnesota 55125
CCOP - Montana Cancer Consortium Billings Montana 59101
Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana 59101
Northern Rockies Radiation Oncology Center Billings Montana 59101
St. Vincent Healthcare Cancer Care Services Billings Montana 59101
Billings Clinic - Downtown Billings Montana 59107-7000
Bozeman Deaconess Cancer Center Bozeman Montana 59715
St. James Healthcare Cancer Care Butte Montana 59701
Great Falls Clinic - Main Facility Great Falls Montana 59405
Great Falls Clinic Great Falls Montana 59405
St. Peter's Hospital Helena Montana 59601
Glacier Oncology, PLLC Kalispell Montana 59901
Kalispell Medical Oncology at KRMC Kalispell Montana 59901
Kalispell Regional Medical Center Kalispell Montana 59901
Community Medical Center Missoula Montana 59801
Guardian Oncology and Center for Wellness Missoula Montana 59804
Montana Cancer Specialists at Montana Cancer Center Missoula Montana 59807-7877
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana 59807
NYU Cancer Institute at New York University Medical Center New York New York 10016
Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx New York 10461
CCOP - MeritCare Hospital Fargo North Dakota 58122
MeritCare Broadway Fargo North Dakota 58122
Mercy Cancer Center at Mercy Medical Center Canton Ohio 44708
Aultman Cancer Center at Aultman Hospital Canton Ohio 44710-1799
Jewish Hospital Cancer Center Cincinnati Ohio 45236
St. Rita's Medical Center Lima Ohio 45801
Geisinger Cancer Institute at Geisinger Health Danville Pennsylvania 17822-0001
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104-4283
Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania 19111-2497
UPMC Cancer Centers Pittsburgh Pennsylvania 15232
Geisinger Medical Group - Scenery Park State College Pennsylvania 16801
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center Wilkes-Barre Pennsylvania 18711
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838
Virginia Commonwealth University Massey Cancer Center Richmond Virginia 23298-0037
Marshfield Clinic Cancer Care at Regional Cancer Center Eau Claire Wisconsin 54701
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin 53792-6164
Marshfield Clinic - Marshfield Center Marshfield Wisconsin 54449
Saint Joseph's Hospital Marshfield Wisconsin 54449
Ministry Medical Group at Saint Mary's Hospital Rhinelander Wisconsin 54501
Marshfield Clinic - Weston Center Weston Wisconsin 54476
Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming 82801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

Recently updated Leukemia trials

Other public records listing Leukemia. Sorted by last update posted; newest first. Not a recommendation.

All Leukemia trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00049517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2023 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00049517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →